The Cost To Bring A New Drug To Market? $1.3bn, JAMA Study Finds
The mean R&D investment required to bring a new drug to market was $1.3bn in a new study estimating pharma R&D costs, lower than the $2.8bn frequently cited from a prior study.
You may also be interested in...
Studies show net prices increases, R&D spending lower than often cited, and better profit margins other industries. But pharma pushes back with concerns about study designs and maintains the picture has changed in more recent years.
Over the past 20 years, the pharmaceutical industry has notched a series of wins with its extraordinary federal lobbying expenditures and campaign contributions. A new JAMA Internal Medicine study examines spending from 1999-2018.
Research published in JAMA shows that the pharmaceutical industry outpaces other industries in the S&P 500 on several measures of profitability.